Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mujoo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Research|February 15, 1987
Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growthK Mujoo, D A Cheresh, H M Yang, et al.
Oncogene|April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinomaK Mujoo, D C Maneval, S C Anderson, et al.
Journal of Biological Response Modifiers|December 1, 1990
Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivoJ L Murray, A A Zukiwski, K Mujoo, et al.
The Journal of Cell Biology|March 1, 1986
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteinsD A Cheresh, M D Pierschbacher, M A Herzig, et al.
Cancer Research|October 1, 1986
Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysisD A Cheresh, J Rosenberg, K Mujoo, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cellsK Mujoo, N J Donato, R Lapushin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1991
Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugateJ L Murray, K Mujoo, C Wilmanns, et al.
The Journal of Biological Chemistry|August 25, 1988
A human brain glycoprotein related to the mouse cell adhesion molecule L1J M Wolff, R Frank, K Mujoo, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cellsM G Rosenblum, L Cheung, S K Kim, et al.
Oncogene|March 26, 2014
The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signalingZ Huang, B-K Choi, K Mujoo, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Research|February 15, 1987
Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growthK Mujoo, D A Cheresh, H M Yang, et al.
Oncogene|April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinomaK Mujoo, D C Maneval, S C Anderson, et al.
Journal of Biological Response Modifiers|December 1, 1990
Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivoJ L Murray, A A Zukiwski, K Mujoo, et al.
The Journal of Cell Biology|March 1, 1986
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteinsD A Cheresh, M D Pierschbacher, M A Herzig, et al.
Cancer Research|October 1, 1986
Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysisD A Cheresh, J Rosenberg, K Mujoo, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cellsK Mujoo, N J Donato, R Lapushin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1991
Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugateJ L Murray, K Mujoo, C Wilmanns, et al.
The Journal of Biological Chemistry|August 25, 1988
A human brain glycoprotein related to the mouse cell adhesion molecule L1J M Wolff, R Frank, K Mujoo, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cellsM G Rosenblum, L Cheung, S K Kim, et al.
Oncogene|March 26, 2014
The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signalingZ Huang, B-K Choi, K Mujoo, et al.
Pageof 3